- Home
- WRBY vs RCKT Comparison
WRBY vs RCKT Comparison
Compare WRBY & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- RCKT
- Stock Information
- Founded
- WRBY 2010
- RCKT 1999
- Country
- WRBY United States
- RCKT United States
- Employees
- WRBY N/A
- RCKT N/A
- Industry
- WRBY Ophthalmic Goods
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- WRBY Health Care
- RCKT Health Care
- Exchange
- WRBY Nasdaq
- RCKT Nasdaq
- Market Cap
- WRBY 1.9B
- RCKT 1.9B
- IPO Year
- WRBY 2021
- RCKT N/A
- Fundamental
- Price
- WRBY $17.23
- RCKT $17.13
- Analyst Decision
- WRBY Buy
- RCKT Strong Buy
- Analyst Count
- WRBY 8
- RCKT 9
- Target Price
- WRBY $16.88
- RCKT $53.22
- AVG Volume (30 Days)
- WRBY 1.4M
- RCKT 731.3K
- Earning Date
- WRBY 11-07-2024
- RCKT 11-04-2024
- Dividend Yield
- WRBY N/A
- RCKT N/A
- EPS Growth
- WRBY N/A
- RCKT N/A
- EPS
- WRBY N/A
- RCKT N/A
- Revenue
- WRBY $719,929,000.00
- RCKT N/A
- Revenue This Year
- WRBY $15.94
- RCKT N/A
- Revenue Next Year
- WRBY $13.07
- RCKT $300.20
- P/E Ratio
- WRBY N/A
- RCKT N/A
- Revenue Growth
- WRBY 13.67
- RCKT N/A
- 52 Week Low
- WRBY $9.83
- RCKT $15.98
- 52 Week High
- WRBY $18.37
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- WRBY 57.79
- RCKT 46.41
- Support Level
- WRBY $16.71
- RCKT $17.05
- Resistance Level
- WRBY $17.86
- RCKT $17.75
- Average True Range (ATR)
- WRBY 0.66
- RCKT 0.72
- MACD
- WRBY 0.01
- RCKT 0.06
- Stochastic Oscillator
- WRBY 62.77
- RCKT 40.23
About WRBY Warby Parker Inc.
Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.